Okayama Medical Center

Running trials

• Recruiting

  General Use-results Surveillance With Awiqli in Patients With Diabetes Mellitus

  NCT06807190· Source

• Active, not recruiting

  Special Use - Results Surveillance on Long-term Use With Wegovy®

  NCT06283667· Source

• Recruiting

  Zephyr Valve Japan Post-Marketing Surveillance

  NCT06332885· Source

• Active, not recruiting

  TrEatment Approach in the Multimodal Era Registry

  NCT05629052· Source

• Active, not recruiting

  A Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused Etentamig (ABBV-383) in Combination With Anti-Cancer Regimens for the Treatment of Adult Participants With Relapsed/Refractory Multiple Myeloma

  NCT05259839· Phase 1· Source

• Active, not recruiting

  A Study to Assess Adverse Events and Change in Disease State of Intravenously (IV) Infused Etentamig (ABBV-383) of Adult Participants With Relapsed or Refractory Multiple Myeloma in Japan

  NCT05286229· Phase 1· Source

• Recruiting

  RESTORE - Study of AGN1 LOEP to Prevent Secondary Hip Fractures

  NCT04796350· Source

• Active, not recruiting

  Study Of Venetoclax Tablet With Intravenous or Subcutaneous Azacitidine to Assess Change in Disease Activity In Adult Participants With Newly Diagnosed Higher-Risk Myelodysplastic Syndrome

  NCT04401748· Phase 3· Source

• Active, not recruiting

  A Study of Sasanlimab in People With Non-muscle Invasive Bladder Cancer

  NCT04165317· Phase 3· Source

• Active, not recruiting

  An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial

  NCT03844048· Phase 3· Source

• Active, not recruiting

  A Study Designed to Evaluate the Safety and Efficacy of Venetoclax Plus Dexamethasone (VenDex) Compared With Pomalidomide Plus Dexamethasone (PomDex) in Participants With t(11;14)-Positive Relapsed or Refractory Multiple Myeloma.

  NCT03539744· Phase 3· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• COPD1 recruiting
• Osteoporosis1 recruiting
• Type 1 diabetes1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  Study of Oral Venetoclax Tablets to Evaluate Adverse Events and Change in Disease Activity in Participants of Any Age With Acute Myeloid Leukemia

  NCT04813263· Source

• Completed

  Post-Marketing Surveillance (Special Use-results Surveillance) on Long-term Use With Ozempic®

  NCT04469855· Source

Trial sites

• Duplicate_Okayama Medical Center /ID# 2409491 trial
• Duplicate_Okayama Medical Center /ID# 2415171 trial
• Okayama Medical Center4 trials
• Okayama Medical Center_Diabetes and Endocrinology1 trial
• Okayama Medical Center /ID# 2001191 trial
• Okayama Medical Center /ID# 2223101 trial
• Okayama Medical Center /ID# 2437591 trial
• Okayama Medical Center /ID# 2458821 trial
• Okayama Medical Center_Cardiology2 trials